Summit Therapeutics Inc.
SMMT
$15.12
$0.251.65%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 690.68M | 598.73M | 713.45M | 238.55M | 297.87M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 29.58M | 17.55M | 6.54M | 7.59M | 11.05M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 317.00K | 316.00K | 316.00K | 321.00K | 319.00K |
| Total Current Assets | 720.58M | 616.60M | 720.30M | 246.47M | 309.24M |
|
|
|||||
| Total Current Assets | 720.58M | 616.60M | 720.30M | 246.47M | 309.24M |
| Net Property, Plant & Equipment | 21.19M | 21.06M | 21.68M | 6.23M | 6.24M |
| Long-term Investments | 1.97M | 1.97M | 2.00M | 2.00M | 2.04M |
| Goodwill | 1.97M | 1.97M | 2.00M | 2.00M | 2.04M |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 8.45M | 8.23M | 7.21M | 7.03M | 6.52M |
| Total Assets | 752.19M | 647.86M | 751.18M | 261.73M | 324.04M |
|
|
|||||
| Total Accounts Payable | 22.90M | 27.55M | 20.29M | 22.25M | 22.98M |
| Total Accrued Expenses | 74.50M | 51.39M | 47.03M | 38.01M | 32.74M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.55M | 3.18M | 3.39M | 2.72M | 3.12M |
| Total Finance Division Other Current Liabilities | 2.62M | 1.15M | 2.28M | 1.96M | 1.49M |
| Total Other Current Liabilities | 2.62M | 1.15M | 2.28M | 1.96M | 1.49M |
| Total Current Liabilities | 103.57M | 83.27M | 72.99M | 64.93M | 60.33M |
|
|
|||||
| Total Current Liabilities | 103.57M | 83.27M | 72.99M | 64.93M | 60.33M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 16.83M | 16.86M | 17.50M | 2.71M | 2.44M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.80M | 1.80M | 1.83M | 1.83M | 1.84M |
| Total Liabilities | 122.20M | 101.92M | 92.32M | 69.47M | 64.60M |
|
|
|||||
| Common Stock & APIC | 3.33B | 3.03B | 2.96B | 2.27B | 2.11B |
| Retained Earnings | -2.70B | -2.48B | -2.29B | -2.07B | -1.84B |
| Treasury Stock & Other | -2.67M | -2.63M | -2.54M | -2.71M | -2.75M |
| Total Common Equity | 629.98M | 545.93M | 658.86M | 192.26M | 259.44M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 629.98M | 545.93M | 658.86M | 192.26M | 259.44M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 629.98M | 545.93M | 658.86M | 192.26M | 259.44M |
|
|
|||||